Moving past regulatory obstacles, Protagonist Therapeutics looks to pivotal tria...
Biogen said that its longtime and polarizing director Alex Denner would step dow...
Biotech executive nominated to Biogen board is mother of director's child, recor...
Suicide hotlines promise anonymity. Dozens of their websites send sensitive data...
Kura faces competition in the menin inhibitor market as the therapy is being dev...
Two broad health reform initiatives are affected by the election.
ViXome showed potent immunomodulatory and pro-reparative effects in pre-clinical...
The NDA submission was based on the findings of the CAPItello-291 Phase III trial.
Syncona launches its third gene therapy company to stake a claim in the ophthalm...
Following a December approval, the FDA has now given Ferring Pharmaceuticals cle...
The activators might represent both an outpatient, oral therapy for chronic hear...
The FDA approval was based on the findings obtained from a double-blind multi-ce...
The recommended dose of Quviviq is one 50mg tablet to be taken orally each night.
The new investment will be used to expand the company’s existing active pharmace...
Telehealth company Ro has paused advertising of the obesity drug Wegovy as the d...
“There’s a biological process ongoing that really explains why people are strugg...
